Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Syndrome and CES1[original query]
Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population.
Clinical and translational science 2016 Jan .
Khalil B M, Shahin M H, Solayman Mhm, Langaee T, Schaalan M F, Gong Y, Hammad L N, Al-Mesallamy H O, Hamdy N M, El-Hammady W A, Johnson J
Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients.
Scientific reports 2017 8 7 (1): 7244.
Xiao Fei-Yan, Luo Jian-Quan, Liu Min, Chen Bi-Lian, Cao Shan, Liu Zhao-Qian, Zhou Hong-Hao, Zhou Gan, Zhang W
Angiotensin-Converting Enzyme Inhibitors' Influence on Antiplatelet Therapy of Clopidogrel in ACS.
Clinical laboratory 2016 Oct 62 (10): 1911-1918.
Yang Shuo, Cui Chanjuan, Zhang Jie, Qiao R
Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.
Clinical pharmacology and therapeutics 2017 Nov 102 (5): 796-804.
Hamzic S, Kummer D, Milesi S, Mueller D, Joerger M, Aebi S, Amstutz U, Largiader C
Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians.
Pharmacogenetics and genomics 2018 Sep 28 (9): 207-213.
Fathy Shaimaa, Shahin Mohamed H, Langaee Taimour, Khalil Basma M, Saleh Ayman, Sabry Nagwa A, Schaalan Mona F, El Wakeel Lamiaa L, Cavallari Larisa
Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort.
Pharmacogenomics 2018 12 20 (2): 75-83.
Melin Kyle, Moon Jee-Young, Qi Qibin, Hernandez-Suarez Dagmar F, Duconge Jorge, Hua Simin, Gonzalez Sara, Zeng Donglin, Kaplan Robert
Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel.
Drug metabolism and personalized therapy 2019 Sep .
Mirzaev Karin B, Osipova Darya V, Kitaeva Elena J, Shprakh Vladimir V, Abdullaev Sherzod P, Andreev Denis A, Mumladze Robert B, Sychev Dmitriy
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.
Pharmacology 2022 Jan 1-11.
Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients.
Pharmaceutics 2023 11 15 (11): .
Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 1 159 114232.
de With Mirjam, van Doorn Leni, Maasland Demi C, Mulder Tessa A M, Oomen-de Hoop Esther, Mostert Bianca, Homs Marjolein Y V, El Bouazzaoui Samira, Mathijssen Ron H J, van Schaik Ron H N, Bins Sand
TOP